Link to this page
Physician Data Query
Id | http://purl.bioontology.org/ontology/PDQ/CDR0000038351
http://purl.bioontology.org/ontology/PDQ/CDR0000038351
|
---|---|
Preferred Name | niacin |
Definitions |
A water-soluble vitamin belonging to the vitamin B family, which occurs in many animal and plant tissues, with antihyperlipidemic activity. Niacin is converted to its active form niacinamide, which is a component of the coenzymes nicotinamide adenine dinucleotide (NAD) and its phosphate form, NADP. These coenzymes play an important role in tissue respiration and in glycogen, lipid, amino acid, protein, and purine metabolism. Although the exact mechanism of action by which niacin lowers cholesterol is not fully understood, it may act by inhibiting the synthesis of very low density lipoproteins (VLDL), inhibiting the release of free fatty acids from adipose tissue, increasing lipoprotein lipase activity, and reducing the hepatic synthesis of VLDL-C and LDL-C. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C689" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C689" NCI Thesaurus)
|
Synonyms |
3-Pyridinecarboxylic Acid
Vitamin B3
nicotinic acid
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
definition | A water-soluble vitamin belonging to the vitamin B family, which occurs in many animal and plant tissues, with antihyperlipidemic activity. Niacin is converted to its active form niacinamide, which is a component of the coenzymes nicotinamide adenine dinucleotide (NAD) and its phosphate form, NADP. These coenzymes play an important role in tissue respiration and in glycogen, lipid, amino acid, protein, and purine metabolism. Although the exact mechanism of action by which niacin lowers cholesterol is not fully understood, it may act by inhibiting the synthesis of very low density lipoproteins (VLDL), inhibiting the release of free fatty acids from adipose tissue, increasing lipoprotein lipase activity, and reducing the hepatic synthesis of VLDL-C and LDL-C. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C689" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C689" NCI Thesaurus) |
---|---|
altLabel |
3-Pyridinecarboxylic Acid
Vitamin B3
nicotinic acid
|
prefLabel |
niacin
|
CAS Registry |
59-67-6
|
notation |
CDR0000038351
|
NSC Code |
169454
|
ORIG STY |
Drug/agent
|
Legacy PDQ ID |
1097
|
Date last modified |
2008-09-22
|
Semantic type UMLS property | |
NCI ID |
C689
|
type | |
tui |
T109
T127
T121
|
cui |
C0027996
C0028027
|
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |